HomeARCH • CVE
add
Arch Biopartners Inc
Previous close
$1.67
Day range
$1.61 - $1.66
Year range
$1.27 - $2.20
Market cap
109.15M CAD
Avg Volume
43.27K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 158.08K | — |
Operating expense | 241.22K | -14.13% |
Net income | -242.33K | 72.60% |
Net profit margin | -153.30 | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 167.46K | 281.05% |
Total assets | 266.46K | -82.69% |
Total liabilities | 3.92M | -51.53% |
Total equity | -3.66M | — |
Shares outstanding | 66.11M | — |
Price to book | -27.83 | — |
Return on assets | -121.24% | — |
Return on capital | 52.33% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -242.33K | 72.60% |
Cash from operations | 113.72K | 113.16% |
Cash from investing | — | — |
Cash from financing | 43.71K | -95.15% |
Net change in cash | 157.43K | 321.08% |
Free cash flow | 139.48K | 124.63% |
About
Founded
1983
Headquarters
Website
